Displaying 1 to 3 of 3 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
MedVantx Inc |
United States | N/A |
||
|
|
Regenesis Biomedical Inc |
United States | 1 Jun 2011 | Series C Active |
|
|
ValenTx Inc Developer of a new therapy to treat patients with obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. |
United States | N/A |